Nextech Invest
Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, TYRA, TNGX, ORIC, ALMS, and represent 85.52% of Nextech Invest's stock portfolio.
- Added to shares of these 6 stocks: CTMX (+$21M), ALMS (+$14M), RLAY (+$8.2M), CRVS (+$6.6M), ENGN, GLUE.
- Started 2 new stock positions in CTMX, CRVS.
- Reduced shares in these 2 stocks: MRSN (-$14M), SPRY.
- Sold out of its position in MRSN.
- Nextech Invest was a net buyer of stock by $37M.
- Nextech Invest has $1.4B in assets under management (AUM), dropping by 37.38%.
- Central Index Key (CIK): 0001595430
Tip: Access up to 7 years of quarterly data
Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nextech Invest
Nextech Invest holds 17 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 52.0 | $739M | 7.6M | 97.25 |
|
|
| Tyra Biosciences (TYRA) | 10.9 | $155M | 4.1M | 38.30 |
|
|
| Tango Therapeutics (TNGX) | 10.7 | $152M | 7.3M | 20.92 |
|
|
| Oric Pharmaceuticals (ORIC) | 6.4 | $91M | 7.2M | 12.67 |
|
|
| Alumis (ALMS) | 5.5 | $78M | +21% | 3.5M | 22.03 |
|
| Relay Therapeutics (RLAY) | 3.9 | $55M | +17% | 5.5M | 9.95 |
|
| Zymeworks Del (ZYME) | 2.0 | $28M | 1.1M | 25.04 |
|
|
| Kymera Therapeutics (KYMR) | 1.6 | $23M | 279k | 83.29 |
|
|
| Cytomx Therapeutics (CTMX) | 1.5 | $21M | NEW | 4.4M | 4.70 |
|
| Context Therapeutics (CNTX) | 1.4 | $19M | 7.4M | 2.62 |
|
|
| Cullinan Oncology (CGEM) | 1.1 | $16M | 1.1M | 14.21 |
|
|
| Engene Holdings (ENGN) | 1.1 | $16M | +9% | 2.3M | 6.81 |
|
| Corvus Pharmaceuticals (CRVS) | 0.5 | $6.6M | NEW | 450k | 14.63 |
|
| Arvinas Ord (ARVN) | 0.4 | $5.7M | 539k | 10.60 |
|
|
| Silence Therapeutics Ads (SLN) | 0.4 | $5.0M | 952k | 5.27 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.4 | $5.0M | +8% | 304k | 16.45 |
|
| Silverback Therapeutics (SPRY) | 0.3 | $4.9M | -7% | 611k | 8.03 |
|
Past Filings by Nextech Invest
SEC 13F filings are viewable for Nextech Invest going back to 2025
- Nextech Invest 2026 Q1 filed May 15, 2026
- Nextech Invest 2025 Q4 filed Feb. 17, 2026
- Nextech Invest 2025 Q3 filed Nov. 14, 2025
- Nextech Invest 2025 Q2 filed Aug. 14, 2025
- Nextech Invest 2025 Q1 filed May 15, 2025